During this highly interactive session, panelists and experts representing policy makers, payers, providers, and patients will debate key challenges in iNHL management in light of recent health policy changes, new value-based models of care delivery, and unprecedented advances in targeted therapi

Join Steven Horwitz, MD and Laura Tang, PharmD, BCOP from Memorial Sloan Kettering Cancer Center as they present their expertise on a range of cases pertaining to peripheral T-cell lymphomas.

This information was originally presented at the NCCN 11^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

This information was originally presented at the NCCN 11^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

This information was originally presented at the NCCN 11^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

This information was originally presented at the NCCN 11^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

Peripheral T-cell lymphomas (PTCLs) represent a relatively uncommon heterogeneous group of non-Hodgkin’s lymphomas (NHLs) with an aggressive clinical course and poor prognosis.

The NCCN 2016 Oncology Nursing Program Webinar Series will provide oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.

This information was originally presented at the NCCN 21^st Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida, from March 31 – April 2, 2016.

This information was originally presented at the NCCN 21^st Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida, from March 31 – April 2, 2016.